Cargando…

The role of coronary artery calcium in allocating pharmacotherapy for primary prevention of cardiovascular disease: The ABCs of CAC

Determining optimal candidates for the numerous potential pharmacotherapies for primary prevention of atherosclerotic cardiovascular disease remains challenging. Selective use of coronary artery calcium (CAC) scoring is recommended by the 2018 and 2019 American Heart Association/American College of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maniar, Yash, Blumenthal, Roger S., Alfaddagh, Abdulhamied
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707562/ https://www.ncbi.nlm.nih.gov/pubmed/36086949 http://dx.doi.org/10.1002/clc.23918

Ejemplares similares

Summarizing 2019 in Cardiovascular Prevention using the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease’s ‘ABC’s Approach
por: Feldman, David I., et al.
Publicado: (2020)

Association between coronary artery calcium and cardiovascular disease as a supporting cause in cancer: The CAC consortium
por: Wang, Frances M., et al.
Publicado: (2020)

Coronary Artery Calcium Data and Reporting System (CAC-DRS): A Primer
por: Kumar, Parveen, et al.
Publicado: (2023)

Automated total and vessel-specific coronary artery calcium (CAC) quantification on chest CT: direct comparison with CAC scoring on non-contrast cardiac CT
por: Yu, Jie, et al.
Publicado: (2022)

Clinical characteristics and outcomes of young adults with first myocardial infarction: Results from Gulf COAST
por: Alfaddagh, Abdulhamied, et al.
Publicado: (2020)

Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial
por: Alfaddagh, Abdulhamied, et al.
Publicado: (2017)

Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
por: Elajami, Tarec K., et al.
Publicado: (2017)

Randomised clinical trial using Coronary Artery Calcium Scoring in Australian Women with Novel Cardiovascular Risk Factors (CAC-WOMEN Trial): study protocol
por: Marschner, Simone, et al.
Publicado: (2022)

Cost-Effectiveness of Coronary Artery Calcium Testing for Coronary Heart and Cardiovascular Disease Risk Prediction to Guide Statin Allocation: The Multi-Ethnic Study of Atherosclerosis (MESA)
por: Roberts, Eric T., et al.
Publicado: (2015)

Implication of thoracic aortic calcification over coronary calcium score regarding the 2018 ACC/AHA Multisociety cholesterol guideline: results from the CAC Consortium
por: Han, Donghee, et al.
Publicado: (2021)

Analyzing Coronary Artery Disease in Patients with Low CAC Scores by 64-Slice MDCT
por: Lu, Nan-Han, et al.
Publicado: (2012)

CAC-Covid-FMJ
por: Possari, R., et al.
Publicado: (2021)

Regression of Coronary Fatty Plaque and Risk of Cardiac Events According to Blood Pressure Status: Data From a Randomized Trial of Eicosapentaenoic Acid and Docosahexaenoic Acid in Patients With Coronary Artery Disease
por: Welty, Francine K., et al.
Publicado: (2023)

Validation of Coronary Artery Disease Reporting and Data System (CAD-RADS) and Application of Coronary Artery Calcium Data and Reporting System (CAC-DRS) as New Standardized Tools in the Management of Coronary Artery Disease Patients
por: Ebaid, Noha Yahia, et al.
Publicado: (2021)

Race/Ethnicity and the Prognostic Implications of Coronary Artery Calcium for All‐Cause and Cardiovascular Disease Mortality: The Coronary Artery Calcium Consortium
por: Orimoloye, Olusola A., et al.
Publicado: (2018)

Coronary Artery Calcification (CAC) and Post‐Trial Cardiovascular Events and Mortality Within the Women's Health Initiative (WHI) Estrogen‐Alone Trial
por: Poornima, Indu G., et al.
Publicado: (2017)

Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention
por: Kohli, Payal, et al.
Publicado: (2014)

Comparison of Preventive Cardiovascular Pharmacotherapy in Surgical vs Percutaneous Coronary Revascularization
por: Barry, Arden R., et al.
Publicado: (2019)

SHORTER LENGTH OFHOSPITAL STAY DURING COVID-19 LOCKDOWN IS NOT ASSOCIATED WITHWORSE 30-DAY OUTCOMES IN ACS PATIENTS
por: Alfaddagh, Abdulhamied, et al.
Publicado: (2023)

Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events
por: Tamargo, Juan, et al.
Publicado: (2022)

Inflammation and cardiovascular disease: From mechanisms to therapeutics
por: Alfaddagh, Abdulhamied, et al.
Publicado: (2020)

The Johns Hopkins Ciccarone Center's expanded ‘ABC's approach to highlight 2020 updates in cardiovascular disease prevention
por: Feldman, David I., et al.
Publicado: (2021)

The Implication of Coronary Artery Calcium Testing for Cardiovascular Disease Prevention and Diabetes
por: Blankstein, Ron, et al.
Publicado: (2017)

Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial)
por: Vossen, Liv M., et al.
Publicado: (2015)

Coronary Artery Calcium in Assessment of Atherosclerotic Cardiovascular Disease Risk and its Role in Primary Prevention
por: Hisamatsu, Takashi, et al.
Publicado: (2023)

Influenza Vaccination for Cardiovascular Prevention: Further Insights from the IAMI Trial and an Updated Meta-analysis
por: Maniar, Yash M., et al.
Publicado: (2022)

Sex disparities in the presentation, management and outcomes of patients with acute coronary syndrome: insights from the ACS QUIK trial
por: Khraishah, Haitham, et al.
Publicado: (2021)

Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry
por: Zubaid, Mohammad, et al.
Publicado: (2020)

Coronary artery calcium and atherosclerotic cardiovascular disease risk in women with early menopause: The Multi-Ethnic Study of Atherosclerosis (MESA)
por: Chu, Jian H., et al.
Publicado: (2022)

Contemporary use of coronary artery calcium for the allocation of aspirin in light of the 2022 USPSTF guideline recommendations
por: Verghese, Dhiran, et al.
Publicado: (2022)

Personalized allocation of acetylsalicylic acid therapy for secondary prevention of coronary artery disease
por: Hegde, Nischal N., et al.
Publicado: (2022)

Cardiovascular Pharmacotherapy Focus
por: Avanzas, Pablo
Publicado: (2019)

Programme of Work of the CERN Audit Committee (CAC) - 2009
Publicado: (2009)

Long COVID and COVID-19-associated cystitis (CAC)
por: Lamb, Laura E., et al.
Publicado: (2021)

Effect of insulin resistance on CAC scores in cancer survivors
por: Jacobi, N., et al.
Publicado: (2023)

An excess vessel in the posterior part of the human cerebral arterial circle (CAC): a case series
por: Vasović, Ljiljana, et al.
Publicado: (2010)

Erratum: Correction of Figure. The Implication of Coronary Artery Calcium Testing for Cardiovascular Disease Prevention and Diabetes
por: Blankstein, Ron, et al.
Publicado: (2017)

Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy
por: Cattaneo, Mattia, et al.
Publicado: (2019)

National Heart Foundation of Australia: position statement on coronary artery calcium scoring for the primary prevention of cardiovascular disease in Australia
por: Jennings, Garry LR, et al.
Publicado: (2021)

Optimal strategy of switching from clopidogrel to ticagrelor in Chinese acute coronary syndrome patients with complicated coronary artery disease: the switching from clopidogrel to ticagrelor (SHIFT-CACS) study
por: Yao, Ying, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jabiam6utf5a0criuacgd0frfa